CO5261547A1 - Profarmacos de higromicina a. - Google Patents

Profarmacos de higromicina a.

Info

Publication number
CO5261547A1
CO5261547A1 CO00082085A CO00082085A CO5261547A1 CO 5261547 A1 CO5261547 A1 CO 5261547A1 CO 00082085 A CO00082085 A CO 00082085A CO 00082085 A CO00082085 A CO 00082085A CO 5261547 A1 CO5261547 A1 CO 5261547A1
Authority
CO
Colombia
Prior art keywords
aryl
alkyl
hydrogen
acyl
amino
Prior art date
Application number
CO00082085A
Other languages
English (en)
Inventor
Kaneko Takushi
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO5261547A1 publication Critical patent/CO5261547A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un compuesto de la fórmula<EMI FILE="00082085_1" ID="1" IMF=JPEG >o una sal farmacéuticamente aceptable de éste, en la que a es 0 ó 1, b es 0, 1, 2 ó 3, R1 es hidrógeno o hidroxi, R2 es metilo, R3 es arilo (C6-C10) opcionalmente sustituido por uno a tres grupos seleccionados independientemente de hidrógeno, halo, alcoxi (C1-C6), amino, alquilamino (C1-C6), ((alquil(C1-C6))2 amino, nitro, alcoxi (C1-C6), alcoxi (C1-C6)C(O), alquilamino (C1-C6)C(O), arilo (C6-C10), heterocicloalquilo (C2-C9), heteroarilo (C2-C9) o alquilo (C1 -C6) opcionalmente sustituido por uno a tres fluoro, X es (R4O)2P(O)-, (R4O)S(O)n, arilo (C6-C10)C(O), heteroarilo (C2-C9)C(O), heterocicloalquilo (C2-C9)C(O), (R7)2N(CHR5)C(O)-, R6piridinioacilo (C1-C6), (R8)3N acilo(C1-C6), acilo(C1-C6), aril (C6-C10)acilo(C1-C3), heteroarilo (C2-C9)acilo (C1-C3) y heterocicloalquilo (C2- C9) acilo (C1-C3), n es 1o 2, R4 es hidrógeno, alquilo(C1-C5), arilo(C6-C10) o un metal alcalino, R5 es hidrógeno, alquilo(C1-C6) opcionalmente sustituido por hidroxi, aminoC(O)-, tio, metiltio, carboxi o amino, arilo (C6-C10) opcionalmente sustituido por hidroxi, o heteroarilo (C2-C9), R6 es hidrógeno, halo, nitro, amino, alquilamino(C1-C6), ((alquil(C1-C6)2)amino, hidroxi, alcoxi(C1-C6), alquiloxi(C1-C6)C(O) o alquilamino(C1-C6)C(O), R7 es hidrógeno, alquilo(C1-C6), arilo(C6-C10) o aril (C6-C10) alquilo (C1-C6), R8 es hidrógeno, alquilo(C1-C6), Y es CH o N, Z es oxígeno o NR12, siendo R12 hidrógeno, alquilo(C1-C6) o arilo (C6-C10), con la condición de que cuando Y es CH, a es 1, ycon la condición de que cuando Y es nitrógeno, a es cero.
CO00082085A 1999-10-29 2000-10-27 Profarmacos de higromicina a. CO5261547A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16272299P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
CO5261547A1 true CO5261547A1 (es) 2003-03-31

Family

ID=22586880

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00082085A CO5261547A1 (es) 1999-10-29 2000-10-27 Profarmacos de higromicina a.

Country Status (32)

Country Link
US (1) US6492342B1 (es)
EP (1) EP1224194A1 (es)
JP (1) JP2003512472A (es)
KR (1) KR20020043255A (es)
CN (1) CN1382149A (es)
AP (1) AP2002002492A0 (es)
AR (1) AR026285A1 (es)
AU (1) AU7307900A (es)
BG (1) BG106635A (es)
BR (1) BR0015156A (es)
CA (1) CA2389019A1 (es)
CO (1) CO5261547A1 (es)
CZ (1) CZ20021347A3 (es)
EA (1) EA200200413A1 (es)
EC (1) ECSP003743A (es)
EE (1) EE200200226A (es)
GT (1) GT200000178A (es)
HK (1) HK1049844A1 (es)
HU (1) HUP0203223A2 (es)
IL (1) IL148580A0 (es)
IS (1) IS6312A (es)
MA (1) MA26839A1 (es)
MX (1) MXPA02004359A (es)
NO (1) NO20021822L (es)
OA (1) OA12079A (es)
PE (1) PE20010757A1 (es)
PL (1) PL357080A1 (es)
SK (1) SK5322002A3 (es)
SV (1) SV2002000210A (es)
TN (1) TNSN00209A1 (es)
TR (1) TR200201143T2 (es)
WO (1) WO2001030793A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3840743A4 (en) * 2018-08-20 2022-08-17 Northeastern University HYGROMYCIN A COMPOUNDS AND METHODS OF TREATING SPIROCHETE DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004303B1 (ru) * 1998-12-02 2004-02-26 Пфайзер Продактс Инк. Производные гигромицина а в качестве антибактериальных агентов

Also Published As

Publication number Publication date
GT200000178A (es) 2002-04-09
IL148580A0 (en) 2002-09-12
EA200200413A1 (ru) 2002-10-31
CA2389019A1 (en) 2001-05-03
TNSN00209A1 (fr) 2005-11-10
AU7307900A (en) 2001-05-08
AP2002002492A0 (en) 2002-06-30
JP2003512472A (ja) 2003-04-02
PL357080A1 (en) 2004-07-12
PE20010757A1 (es) 2001-07-25
MA26839A1 (fr) 2004-12-20
IS6312A (is) 2002-03-19
WO2001030793A1 (en) 2001-05-03
MXPA02004359A (es) 2002-11-07
BR0015156A (pt) 2002-07-16
BG106635A (en) 2002-12-29
CN1382149A (zh) 2002-11-27
US6492342B1 (en) 2002-12-10
NO20021822D0 (no) 2002-04-18
ECSP003743A (es) 2002-05-23
NO20021822L (no) 2002-04-18
HUP0203223A2 (en) 2003-02-28
HK1049844A1 (zh) 2003-05-30
OA12079A (en) 2006-05-04
CZ20021347A3 (cs) 2002-11-13
EE200200226A (et) 2003-06-16
SK5322002A3 (en) 2003-01-09
SV2002000210A (es) 2002-06-07
TR200201143T2 (tr) 2002-08-21
KR20020043255A (ko) 2002-06-08
AR026285A1 (es) 2003-02-05
EP1224194A1 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
CO5261551A1 (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas
HK1065542A1 (en) Thieno (2,3-d)pyrimidinediones as inhibitors of t-cells sproliferation
EP1288199A4 (en) INHIBITORS OF MMP-12
ES2184268T3 (es) Oligomeros de organosilanos.
KR950700894A (ko) 탁솔 유도체(Taxol derivatives)
RU2008126277A (ru) Соединение-предшественник органического соединения, меченного радиоактивным галогеном
NZ511394A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
HK1079191A1 (en) Pleuromutilin derivatives as antimicrobbials
CA2282834A1 (en) Novel hexanoic acid derivatives
HUP0402235A2 (hu) 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények
DK1215201T3 (da) Fremgangsmåde til fremstilling af aryloctanylamider
AU2003207432A1 (en) Urea linker derivatives for use as ppar modulators
TW200621719A (en) Color filter for electronic display device and squarylium compound metal complex
CO5261547A1 (es) Profarmacos de higromicina a.
DK1559714T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivater og 3-aminothiophenderivater
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
ES2182523T3 (es) Derivados de indolilo como agentes serotonergicos.
BR0210512A (pt) Processo de decomposição papa o ácido (r)-(-)-2-hidroxi-2-(2-clorofenil) acético
DE60329668D1 (de) Verfahren zur unterdrückung der ptx3 genexpression
EA200200665A1 (ru) Новые соединения бензолсульфонамида, способ их получения и фармацевтические композиции, их содержащие
AP2001002314A0 (en) Substituted benzolactam compounds.
PT96757A (pt) Processo de preparacao de derivados de indolo e de composicoes farmaceuticas
DK1546096T3 (da) Fremgangsmåde til fremstilling af aminopyrrolidinderivater
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
HUP0002314A2 (hu) Glicidil-észter és glicidil-észtert tartalmazó hőre keményedő gyantakészítmény

Legal Events

Date Code Title Description
FC Application refused